Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0426980 (
motor symptom
)
471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Motor symptoms
in Parkinson's disease (PD) are associated with complex changes of firing properties in basal ganglia output neurons (BGON). The abnormalities are generally attributed to altered synaptic input and potential post-synaptic mechanisms are currently unknown. Our cell-type selective transcriptome analyses of BGON in the rat 6-hydroxydopamine (6-OHDA) model of PD identified the ion channel
HCN3
as a likely contributor to altered neuronal excitability. Quantitative PCR experiments confirmed the
HCN3
upregulation in the rat and mouse 6-OHDA models and also demonstrated selectivity of the effect for
HCN3
. In accordance with the mRNA expression data, in vitro whole cell patch-clamp recordings in BGON showed increased
HCN3
current amplitudes and increased rebound excitability in BGON of 6-OHDA treated rats. These data establish
HCN3
up-regulation as a novel candidate mechanism that might contribute to the in vivo changes of electrical activity in basal ganglia output neurons of the parkinsonian brain.
...
PMID:Dopamine depletion induced up-regulation of HCN3 enhances rebound excitability of basal ganglia output neurons. 1932 57